Gene Symbol | Gene ID | Gene Info |
---|---|---|
Lhx2
|
ENSMUSG00000000247.5 | LIM homeobox protein 2 |
Hoxc5
|
ENSMUSG00000022485.3 | homeobox C5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr15_102968570_102969183 | Hoxc5 | 1433 | 0.186816 | 0.19 | 1.4e-01 | Click! |
chr15_103011882_103012844 | Hoxc5 | 1452 | 0.193720 | 0.15 | 2.5e-01 | Click! |
chr15_102967711_102968059 | Hoxc5 | 442 | 0.569265 | 0.11 | 3.9e-01 | Click! |
chr15_102969621_102969772 | Hoxc5 | 2253 | 0.122959 | 0.10 | 4.3e-01 | Click! |
chr15_103013375_103013526 | Hoxc5 | 365 | 0.679724 | -0.08 | 5.7e-01 | Click! |
chr2_38338844_38339252 | Lhx2 | 233 | 0.906134 | 0.52 | 2.1e-05 | Click! |
chr2_38350368_38351189 | Lhx2 | 19 | 0.965999 | 0.50 | 4.1e-05 | Click! |
chr2_38351207_38353752 | Lhx2 | 53 | 0.964935 | 0.47 | 1.7e-04 | Click! |
chr2_38355912_38358148 | Lhx2 | 3228 | 0.183684 | 0.43 | 6.3e-04 | Click! |
chr2_38354292_38355594 | Lhx2 | 1141 | 0.408777 | 0.41 | 1.1e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr16_43504464_43505047 | 6.50 |
Zbtb20 |
zinc finger and BTB domain containing 20 |
1058 |
0.61 |
chr9_41582824_41584205 | 6.34 |
Mir125b-1 |
microRNA 125b-1 |
1588 |
0.2 |
chr10_29143400_29144848 | 6.30 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr2_18042311_18043883 | 5.29 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr5_48598987_48600332 | 4.97 |
Kcnip4 |
Kv channel interacting protein 4 |
23 |
0.97 |
chr9_41585694_41587243 | 4.77 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1301 |
0.29 |
chrX_153501207_153502250 | 4.72 |
Ubqln2 |
ubiquilin 2 |
3501 |
0.22 |
chr2_140668225_140669392 | 4.65 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
2592 |
0.43 |
chr7_29071185_29072068 | 4.39 |
Gm26604 |
predicted gene, 26604 |
11 |
0.87 |
chr15_25415436_25415919 | 4.26 |
Gm48957 |
predicted gene, 48957 |
614 |
0.58 |
chr11_36676450_36677161 | 4.25 |
Tenm2 |
teneurin transmembrane protein 2 |
940 |
0.7 |
chr18_54125378_54126373 | 4.13 |
Gm8594 |
predicted gene 8594 |
94567 |
0.09 |
chr13_83739310_83740387 | 4.12 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
985 |
0.29 |
chr16_63863108_63864179 | 4.08 |
Epha3 |
Eph receptor A3 |
230 |
0.96 |
chr3_86544323_86545126 | 4.08 |
Lrba |
LPS-responsive beige-like anchor |
2031 |
0.33 |
chr18_80984086_80984990 | 4.08 |
Sall3 |
spalt like transcription factor 3 |
1998 |
0.23 |
chr3_134236641_134237783 | 3.99 |
Cxxc4 |
CXXC finger 4 |
392 |
0.78 |
chr11_34315414_34316667 | 3.97 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr14_98164357_98165375 | 3.97 |
Dach1 |
dachshund family transcription factor 1 |
4677 |
0.28 |
chr3_86545154_86545526 | 3.82 |
Lrba |
LPS-responsive beige-like anchor |
1415 |
0.43 |
chr7_92234907_92236280 | 3.76 |
Dlg2 |
discs large MAGUK scaffold protein 2 |
466 |
0.88 |
chr18_43686487_43688415 | 3.75 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr11_97841566_97842003 | 3.72 |
B230217C12Rik |
RIKEN cDNA B230217C12 gene |
465 |
0.67 |
chr3_86543379_86544222 | 3.71 |
Lrba |
LPS-responsive beige-like anchor |
1767 |
0.38 |
chr9_35424475_35426234 | 3.66 |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
1766 |
0.31 |
chr3_38892303_38893788 | 3.66 |
Fat4 |
FAT atypical cadherin 4 |
2103 |
0.36 |
chrX_23283125_23283785 | 3.65 |
Klhl13 |
kelch-like 13 |
1374 |
0.57 |
chr12_89815214_89815490 | 3.64 |
Nrxn3 |
neurexin III |
2869 |
0.41 |
chr13_15466077_15468087 | 3.63 |
Gli3 |
GLI-Kruppel family member GLI3 |
3102 |
0.22 |
chr12_29534253_29535510 | 3.61 |
Gm20208 |
predicted gene, 20208 |
10 |
0.8 |
chr1_77512287_77513134 | 3.57 |
Epha4 |
Eph receptor A4 |
2369 |
0.26 |
chr18_65583033_65584701 | 3.40 |
Zfp532 |
zinc finger protein 532 |
70 |
0.95 |
chr1_14307063_14308005 | 3.34 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
2302 |
0.39 |
chr18_57468245_57468987 | 3.30 |
Ctxn3 |
cortexin 3 |
94 |
0.97 |
chr11_94044930_94045437 | 3.24 |
Spag9 |
sperm associated antigen 9 |
818 |
0.6 |
chr12_71048832_71049275 | 3.20 |
Arid4a |
AT rich interactive domain 4A (RBP1-like) |
712 |
0.65 |
chrX_133682515_133683917 | 3.18 |
Pcdh19 |
protocadherin 19 |
1775 |
0.49 |
chr12_52700044_52701597 | 3.16 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
1437 |
0.46 |
chr2_57613916_57615034 | 3.15 |
Gm13532 |
predicted gene 13532 |
14753 |
0.2 |
chr9_83663941_83664341 | 3.13 |
Gm36120 |
predicted gene, 36120 |
23384 |
0.17 |
chr11_23893045_23893724 | 3.13 |
Gm12061 |
predicted gene 12061 |
1176 |
0.38 |
chr4_54950838_54951442 | 3.12 |
Zfp462 |
zinc finger protein 462 |
3164 |
0.35 |
chr17_17402413_17403374 | 3.07 |
Lix1 |
limb and CNS expressed 1 |
221 |
0.91 |
chr9_41377643_41378358 | 3.07 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
1439 |
0.4 |
chr4_49842278_49843034 | 3.04 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
2893 |
0.36 |
chr18_23036665_23037864 | 3.00 |
Nol4 |
nucleolar protein 4 |
1392 |
0.59 |
chr6_143259703_143261097 | 2.97 |
D6Ertd474e |
DNA segment, Chr 6, ERATO Doi 474, expressed |
14507 |
0.2 |
chrX_52914554_52915519 | 2.95 |
Phf6 |
PHD finger protein 6 |
2741 |
0.19 |
chr13_83735558_83735982 | 2.94 |
Gm33366 |
predicted gene, 33366 |
2765 |
0.16 |
chr4_103619552_103620735 | 2.91 |
Dab1 |
disabled 1 |
478 |
0.8 |
chr1_81077232_81078427 | 2.89 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
246 |
0.96 |
chr10_125967796_125968797 | 2.89 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2043 |
0.45 |
chr17_4997980_4998900 | 2.89 |
Arid1b |
AT rich interactive domain 1B (SWI-like) |
2011 |
0.4 |
chr15_92598307_92599654 | 2.86 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr15_59647131_59647282 | 2.85 |
Trib1 |
tribbles pseudokinase 1 |
1144 |
0.52 |
chr1_66386919_66387899 | 2.84 |
Map2 |
microtubule-associated protein 2 |
398 |
0.87 |
chr4_48586297_48586448 | 2.83 |
Tmeff1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
821 |
0.65 |
chr12_41483283_41485192 | 2.83 |
Lrrn3 |
leucine rich repeat protein 3, neuronal |
2194 |
0.36 |
chr6_15188050_15189424 | 2.83 |
Foxp2 |
forkhead box P2 |
3174 |
0.4 |
chr1_111862798_111863699 | 2.82 |
Dsel |
dermatan sulfate epimerase-like |
1520 |
0.41 |
chr13_83715222_83716973 | 2.82 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr16_74410085_74410783 | 2.80 |
Robo2 |
roundabout guidance receptor 2 |
478 |
0.87 |
chr6_96113911_96115198 | 2.80 |
Tafa1 |
TAFA chemokine like family member 1 |
95 |
0.98 |
chrX_106921477_106921682 | 2.77 |
Lpar4 |
lysophosphatidic acid receptor 4 |
954 |
0.64 |
chr2_95232237_95232956 | 2.76 |
Gm13794 |
predicted gene 13794 |
161646 |
0.04 |
chr5_70842167_70842810 | 2.74 |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
129 |
0.98 |
chr1_42259362_42260538 | 2.73 |
Gm28175 |
predicted gene 28175 |
1905 |
0.34 |
chr3_34653590_34654523 | 2.72 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1980 |
0.2 |
chr5_116312100_116312726 | 2.72 |
B230112J18Rik |
RIKEN cDNA B230112J18 gene |
53 |
0.96 |
chr3_34654574_34655689 | 2.70 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
905 |
0.42 |
chr8_34325722_34326983 | 2.69 |
Gm4889 |
predicted gene 4889 |
1558 |
0.28 |
chr16_63860769_63861945 | 2.68 |
Epha3 |
Eph receptor A3 |
2056 |
0.46 |
chr17_90452868_90453681 | 2.65 |
Nrxn1 |
neurexin I |
1548 |
0.36 |
chr3_8512495_8512918 | 2.65 |
Stmn2 |
stathmin-like 2 |
3120 |
0.28 |
chr9_41587250_41587725 | 2.63 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
282 |
0.84 |
chr5_116895246_116895637 | 2.63 |
Gm43122 |
predicted gene 43122 |
64887 |
0.1 |
chr2_80445040_80445201 | 2.60 |
Frzb |
frizzled-related protein |
2505 |
0.28 |
chr2_64092860_64093848 | 2.60 |
Fign |
fidgetin |
4634 |
0.37 |
chr9_41584760_41585051 | 2.60 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2864 |
0.14 |
chr15_92596927_92597853 | 2.59 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
264 |
0.95 |
chr13_97248475_97250229 | 2.59 |
Enc1 |
ectodermal-neural cortex 1 |
8247 |
0.17 |
chr15_98952050_98952507 | 2.59 |
Gm49450 |
predicted gene, 49450 |
1273 |
0.2 |
chr12_72233267_72233815 | 2.59 |
Rtn1 |
reticulon 1 |
2198 |
0.35 |
chr3_57846307_57846818 | 2.58 |
Pfn2 |
profilin 2 |
583 |
0.72 |
chr13_83736071_83736534 | 2.58 |
Gm33366 |
predicted gene, 33366 |
2233 |
0.18 |
chr13_83718912_83719403 | 2.58 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2224 |
0.22 |
chr18_54719777_54720132 | 2.56 |
Gm5821 |
predicted gene 5821 |
46178 |
0.16 |
chr4_114842209_114842913 | 2.56 |
Gm23230 |
predicted gene, 23230 |
2556 |
0.25 |
chr13_83735228_83735549 | 2.54 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2822 |
0.16 |
chr2_92188323_92189316 | 2.54 |
Phf21a |
PHD finger protein 21A |
2354 |
0.24 |
chr8_23669376_23670424 | 2.53 |
Zmat4 |
zinc finger, matrin type 4 |
226 |
0.95 |
chr10_90578974_90579573 | 2.51 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
2281 |
0.42 |
chr7_137318563_137320070 | 2.50 |
Ebf3 |
early B cell factor 3 |
4871 |
0.21 |
chr4_154630838_154632339 | 2.50 |
Prdm16 |
PR domain containing 16 |
5209 |
0.14 |
chr1_143641893_143642230 | 2.49 |
Cdc73 |
cell division cycle 73, Paf1/RNA polymerase II complex component |
464 |
0.75 |
chr15_25411393_25411893 | 2.49 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
2055 |
0.24 |
chrX_100778957_100779501 | 2.48 |
Dlg3 |
discs large MAGUK scaffold protein 3 |
1944 |
0.3 |
chr8_34890130_34891317 | 2.47 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
572 |
0.8 |
chr3_125403648_125404947 | 2.47 |
Ndst4 |
N-deacetylase/N-sulfotransferase (heparin glucosaminyl) 4 |
207 |
0.97 |
chr13_83732205_83734272 | 2.47 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr19_4758474_4759201 | 2.47 |
Rbm4b |
RNA binding motif protein 4B |
1932 |
0.18 |
chr4_72204195_72205177 | 2.46 |
C630043F03Rik |
RIKEN cDNA C630043F03 gene |
3338 |
0.25 |
chr3_152106774_152107680 | 2.45 |
Gipc2 |
GIPC PDZ domain containing family, member 2 |
195 |
0.8 |
chr11_32001099_32002296 | 2.45 |
Nsg2 |
neuron specific gene family member 2 |
1195 |
0.52 |
chr6_7554855_7556232 | 2.45 |
Tac1 |
tachykinin 1 |
447 |
0.85 |
chr9_52148115_52149635 | 2.43 |
Zc3h12c |
zinc finger CCCH type containing 12C |
19236 |
0.18 |
chr13_40727690_40728914 | 2.43 |
Gm26688 |
predicted gene, 26688 |
494 |
0.48 |
chr11_96334278_96335532 | 2.43 |
Hoxb3 |
homeobox B3 |
6040 |
0.08 |
chr13_78191797_78192284 | 2.42 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1597 |
0.28 |
chr3_38894285_38895428 | 2.42 |
Fat4 |
FAT atypical cadherin 4 |
3914 |
0.27 |
chr8_55939901_55941088 | 2.41 |
Glra3 |
glycine receptor, alpha 3 subunit |
15 |
0.98 |
chr18_81165961_81166641 | 2.41 |
4930594M17Rik |
RIKEN cDNA 4930594M17 gene |
69765 |
0.09 |
chr13_44842150_44842855 | 2.41 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
1719 |
0.39 |
chr10_90577565_90578158 | 2.41 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
869 |
0.72 |
chr13_8202516_8203999 | 2.40 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
335 |
0.87 |
chr2_52038470_52039720 | 2.37 |
Tnfaip6 |
tumor necrosis factor alpha induced protein 6 |
1086 |
0.54 |
chr1_138346039_138346510 | 2.37 |
Gm28500 |
predicted gene 28500 |
30990 |
0.17 |
chr1_194621653_194621902 | 2.36 |
Plxna2 |
plexin A2 |
1952 |
0.34 |
chr14_93883900_93884713 | 2.35 |
Pcdh9 |
protocadherin 9 |
1442 |
0.55 |
chr13_81785658_81786344 | 2.35 |
Cetn3 |
centrin 3 |
1294 |
0.4 |
chr13_34132999_34133150 | 2.34 |
Gm36500 |
predicted gene, 36500 |
786 |
0.46 |
chr6_145047358_145048434 | 2.34 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
43 |
0.82 |
chr7_92739016_92739469 | 2.34 |
4632427E13Rik |
RIKEN cDNA 4632427E13 gene |
2217 |
0.19 |
chr14_61043748_61044093 | 2.32 |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
2549 |
0.3 |
chr14_100374663_100375528 | 2.32 |
Gm26367 |
predicted gene, 26367 |
43388 |
0.15 |
chr16_67618113_67618498 | 2.31 |
Cadm2 |
cell adhesion molecule 2 |
2188 |
0.39 |
chr1_168426195_168428871 | 2.31 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr7_135853686_135854203 | 2.30 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
262 |
0.7 |
chr1_42686011_42687379 | 2.29 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
6398 |
0.14 |
chr3_68572046_68573169 | 2.26 |
Schip1 |
schwannomin interacting protein 1 |
362 |
0.89 |
chr8_54954519_54955779 | 2.25 |
Gpm6a |
glycoprotein m6a |
306 |
0.88 |
chr13_28881136_28881895 | 2.25 |
2610307P16Rik |
RIKEN cDNA 2610307P16 gene |
1941 |
0.32 |
chr17_51760240_51761547 | 2.24 |
C230085N15Rik |
RIKEN cDNA C230085N15 gene |
728 |
0.54 |
chr1_19215607_19218714 | 2.24 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr17_11664263_11665109 | 2.24 |
Gm10513 |
predicted gene 10513 |
67659 |
0.13 |
chr2_73775928_73776225 | 2.24 |
Chn1 |
chimerin 1 |
730 |
0.7 |
chrX_96456094_96457321 | 2.23 |
Heph |
hephaestin |
279 |
0.62 |
chr3_5224377_5225076 | 2.23 |
Zfhx4 |
zinc finger homeodomain 4 |
3221 |
0.24 |
chr18_37217058_37218378 | 2.23 |
Gm10544 |
predicted gene 10544 |
39196 |
0.08 |
chr18_59062200_59063436 | 2.22 |
Minar2 |
membrane integral NOTCH2 associated receptor 2 |
307 |
0.94 |
chr2_6881042_6881689 | 2.22 |
Gm13389 |
predicted gene 13389 |
2905 |
0.24 |
chr5_13125231_13126281 | 2.22 |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
163 |
0.95 |
chr9_26733853_26734637 | 2.21 |
B3gat1 |
beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) |
394 |
0.83 |
chr11_118907285_118907593 | 2.21 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
566 |
0.76 |
chrX_166346941_166347276 | 2.21 |
Gpm6b |
glycoprotein m6b |
2266 |
0.36 |
chr12_98577628_98578516 | 2.21 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
238 |
0.9 |
chr1_178531534_178532270 | 2.21 |
Kif26b |
kinesin family member 26B |
2777 |
0.33 |
chr7_76393110_76393610 | 2.20 |
Agbl1 |
ATP/GTP binding protein-like 1 |
17702 |
0.28 |
chr2_135323864_135324089 | 2.20 |
Plcb1 |
phospholipase C, beta 1 |
74803 |
0.12 |
chr11_118907979_118908224 | 2.20 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
96 |
0.97 |
chr1_72284325_72285141 | 2.19 |
Tmem169 |
transmembrane protein 169 |
338 |
0.53 |
chr12_49387532_49388566 | 2.18 |
3110039M20Rik |
RIKEN cDNA 3110039M20 gene |
1603 |
0.26 |
chr18_79106634_79106785 | 2.17 |
Setbp1 |
SET binding protein 1 |
2682 |
0.4 |
chr2_140669998_140670175 | 2.17 |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
1314 |
0.62 |
chr5_5664640_5664930 | 2.17 |
Cfap69 |
cilia and flagella associated protein 69 |
546 |
0.74 |
chr13_55962186_55963636 | 2.16 |
Gm47071 |
predicted gene, 47071 |
39354 |
0.14 |
chrX_160992631_160993204 | 2.16 |
Cdkl5 |
cyclin-dependent kinase-like 5 |
1787 |
0.46 |
chr5_107497766_107498034 | 2.15 |
Btbd8 |
BTB (POZ) domain containing 8 |
121 |
0.94 |
chr16_78574173_78574418 | 2.15 |
D16Ertd472e |
DNA segment, Chr 16, ERATO Doi 472, expressed |
2339 |
0.28 |
chr1_14303973_14305599 | 2.14 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
158 |
0.97 |
chr3_30010716_30011762 | 2.14 |
Mecom |
MDS1 and EVI1 complex locus |
200 |
0.91 |
chr1_138840496_138840948 | 2.13 |
Lhx9 |
LIM homeobox protein 9 |
1707 |
0.3 |
chr13_84063384_84064052 | 2.13 |
Gm17750 |
predicted gene, 17750 |
1054 |
0.58 |
chr7_126951595_126952206 | 2.13 |
Sez6l2 |
seizure related 6 homolog like 2 |
934 |
0.25 |
chr6_144207785_144208224 | 2.13 |
Sox5 |
SRY (sex determining region Y)-box 5 |
1448 |
0.58 |
chr11_94045498_94046076 | 2.13 |
Spag9 |
sperm associated antigen 9 |
1422 |
0.4 |
chr2_32428080_32429746 | 2.13 |
Slc25a25 |
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
1839 |
0.19 |
chr1_19213854_19215338 | 2.13 |
Tfap2b |
transcription factor AP-2 beta |
717 |
0.69 |
chr5_69339559_69339732 | 2.13 |
Gm24368 |
predicted gene, 24368 |
1138 |
0.38 |
chr4_102588865_102590254 | 2.12 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
164 |
0.97 |
chr8_61227862_61229170 | 2.12 |
Sh3rf1 |
SH3 domain containing ring finger 1 |
4272 |
0.23 |
chr1_81593421_81594539 | 2.10 |
Gm6198 |
predicted gene 6198 |
36497 |
0.2 |
chr14_108910678_108911967 | 2.10 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
2836 |
0.42 |
chr1_90204802_90205464 | 2.09 |
Ackr3 |
atypical chemokine receptor 3 |
1127 |
0.47 |
chr13_78196283_78196791 | 2.09 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
164 |
0.91 |
chr9_71892666_71893902 | 2.09 |
Tcf12 |
transcription factor 12 |
2701 |
0.17 |
chr9_71894609_71895239 | 2.08 |
Tcf12 |
transcription factor 12 |
1061 |
0.37 |
chr2_174291330_174292221 | 2.08 |
Gnasas1 |
GNAS antisense RNA 1 |
3614 |
0.16 |
chr18_14502717_14503687 | 2.08 |
Gm50098 |
predicted gene, 50098 |
11197 |
0.23 |
chr3_66976156_66976605 | 2.08 |
Shox2 |
short stature homeobox 2 |
2067 |
0.29 |
chr4_143298537_143299593 | 2.07 |
Pdpn |
podoplanin |
398 |
0.83 |
chr5_131532921_131534054 | 2.07 |
Auts2 |
autism susceptibility candidate 2 |
910 |
0.58 |
chr10_21882056_21883261 | 2.06 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
289 |
0.9 |
chr12_95466879_95467383 | 2.06 |
Gm26055 |
predicted gene, 26055 |
88180 |
0.09 |
chr3_55782023_55782190 | 2.06 |
Mab21l1 |
mab-21-like 1 |
404 |
0.8 |
chr11_28582033_28582291 | 2.05 |
Ccdc85a |
coiled-coil domain containing 85A |
1833 |
0.45 |
chr1_177444257_177446079 | 2.05 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
230 |
0.9 |
chr11_117482269_117483090 | 2.04 |
Gm34418 |
predicted gene, 34418 |
82 |
0.95 |
chr13_115346333_115347310 | 2.03 |
Gm47891 |
predicted gene, 47891 |
64620 |
0.13 |
chr7_69992152_69993326 | 2.03 |
Gm24120 |
predicted gene, 24120 |
34835 |
0.18 |
chrX_166344665_166345995 | 2.03 |
Gpm6b |
glycoprotein m6b |
488 |
0.85 |
chr1_174920917_174922100 | 2.03 |
Grem2 |
gremlin 2, DAN family BMP antagonist |
311 |
0.94 |
chr14_76420544_76421824 | 2.02 |
Tsc22d1 |
TSC22 domain family, member 1 |
2356 |
0.39 |
chr7_137306984_137307575 | 2.01 |
Ebf3 |
early B cell factor 3 |
6637 |
0.2 |
chrX_166344270_166344507 | 2.01 |
Gpm6b |
glycoprotein m6b |
304 |
0.92 |
chr4_68953001_68953567 | 2.01 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
1113 |
0.68 |
chr7_51880136_51880838 | 2.01 |
Gas2 |
growth arrest specific 2 |
156 |
0.95 |
chr8_41054476_41055299 | 2.01 |
Mtus1 |
mitochondrial tumor suppressor 1 |
93 |
0.95 |
chr18_80982763_80983698 | 2.00 |
Sall3 |
spalt like transcription factor 3 |
3306 |
0.17 |
chr19_20009817_20010437 | 2.00 |
Gm22684 |
predicted gene, 22684 |
23508 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.7 | 5.2 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.5 | 7.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.5 | 3.0 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.4 | 5.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
1.4 | 7.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.3 | 5.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.2 | 5.0 | GO:0060594 | mammary gland specification(GO:0060594) |
1.2 | 4.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.1 | 12.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.1 | 2.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.1 | 2.2 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) |
1.1 | 3.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.1 | 3.2 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.0 | 4.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.0 | 2.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.0 | 2.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.0 | 7.7 | GO:0031223 | auditory behavior(GO:0031223) |
0.9 | 8.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.9 | 2.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.9 | 4.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 6.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.9 | 6.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.9 | 2.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.9 | 2.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.8 | 3.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.8 | 1.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 2.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.8 | 2.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.8 | 3.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.8 | 3.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.7 | 6.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 3.0 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.7 | 3.0 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.7 | 2.9 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.7 | 1.4 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.7 | 2.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.7 | 2.8 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.7 | 2.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.7 | 2.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.7 | 3.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.7 | 3.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.6 | 1.9 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 3.2 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.6 | 9.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.6 | 1.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 2.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.6 | 1.8 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.6 | 2.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.6 | 1.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 1.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 1.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.6 | 3.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.6 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 1.7 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.5 | 2.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 1.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.5 | 2.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.5 | 3.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 1.6 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.5 | 7.8 | GO:0008038 | neuron recognition(GO:0008038) |
0.5 | 0.5 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.5 | 2.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.5 | 2.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.5 | 1.5 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.5 | 2.5 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.5 | 2.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 1.5 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 3.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.5 | 2.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.5 | 1.0 | GO:0008050 | female courtship behavior(GO:0008050) |
0.5 | 2.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.5 | 0.5 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.5 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.5 | 0.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.5 | 1.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.5 | 0.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 0.9 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.5 | 0.9 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 1.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.4 | 1.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.4 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 0.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 1.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 2.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 1.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 5.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 4.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) |
0.4 | 1.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.4 | 2.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.4 | 2.0 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.4 | 2.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 1.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.4 | 1.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 2.7 | GO:0060074 | synapse maturation(GO:0060074) |
0.4 | 1.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 1.9 | GO:0060026 | convergent extension(GO:0060026) |
0.4 | 1.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.4 | 1.1 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.4 | 1.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 0.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.4 | 1.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.4 | 1.5 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 0.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.4 | 6.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 2.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 0.7 | GO:0090427 | activation of meiosis(GO:0090427) |
0.4 | 1.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.4 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.4 | 0.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.3 | 0.3 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.3 | 0.7 | GO:0044333 | planar cell polarity pathway involved in axis elongation(GO:0003402) Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 2.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.0 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 7.5 | GO:0001964 | startle response(GO:0001964) |
0.3 | 1.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.3 | 1.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 2.3 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 1.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.3 | 0.6 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 16.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.3 | 2.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 3.3 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.3 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.3 | 0.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 1.2 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 1.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.3 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.3 | 0.6 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.3 | 0.9 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 0.3 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.3 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 1.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.3 | 2.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.3 | 0.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 1.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.3 | 0.5 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.3 | 20.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.3 | 1.4 | GO:0035989 | tendon development(GO:0035989) |
0.3 | 0.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.3 | 0.5 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.3 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.3 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 0.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.3 | 0.8 | GO:0045112 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 1.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 1.0 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 1.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 | 1.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 0.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.5 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 1.2 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.7 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 1.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 0.7 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.2 | 0.2 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.7 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.2 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.2 | 0.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.2 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.2 | 2.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.2 | 0.2 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.2 | 0.9 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.7 | GO:0032364 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.2 | 0.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.2 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.2 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.2 | 0.5 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.2 | 4.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.9 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 1.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 1.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 1.9 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.2 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 4.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.2 | 2.5 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 0.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 0.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 1.0 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.2 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 1.4 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.2 | 0.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.2 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 1.0 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 0.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 1.4 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.2 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 0.2 | GO:1904238 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.2 | 0.6 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.4 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.2 | 0.8 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.6 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.2 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.5 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.2 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.7 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 0.2 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 0.7 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.2 | 0.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 1.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.2 | 0.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.3 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.2 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 3.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.7 | GO:0061548 | ganglion development(GO:0061548) |
0.2 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 2.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.2 | 1.5 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 4.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 0.5 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.2 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.2 | 0.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.2 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 1.3 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 2.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.2 | 2.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 0.5 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.2 | 2.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 0.6 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.5 | GO:0045876 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) positive regulation of sister chromatid cohesion(GO:0045876) |
0.2 | 0.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 0.6 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 2.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 0.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 1.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.2 | 2.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.2 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 2.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.1 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.1 | 4.1 | GO:0021549 | cerebellum development(GO:0021549) |
0.1 | 0.3 | GO:0044849 | estrous cycle(GO:0044849) |
0.1 | 0.4 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.1 | 0.4 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 1.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
0.1 | 1.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.4 | GO:2001023 | regulation of response to drug(GO:2001023) positive regulation of response to drug(GO:2001025) |
0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.1 | 0.3 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 1.3 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 1.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.3 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.4 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.3 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
0.1 | 0.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.4 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 1.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 1.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 1.1 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.4 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.5 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.4 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.8 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 1.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 1.3 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.5 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.1 | 0.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.5 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 1.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.5 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.1 | 0.5 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 1.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.1 | 0.5 | GO:0072610 | interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) |
0.1 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.4 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 1.6 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.1 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.1 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.1 | 0.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 0.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.2 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 1.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.6 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.1 | GO:0010255 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.2 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 0.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.7 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.1 | 0.1 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 2.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 3.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 0.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 2.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 1.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.6 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.2 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.7 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.2 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.1 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.1 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.1 | 0.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 1.1 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.6 | GO:1904888 | cranial skeletal system development(GO:1904888) |
0.1 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.3 | GO:0051454 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.3 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.3 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.1 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.2 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.1 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.4 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.4 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 1.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 5.9 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.5 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.7 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 1.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 2.0 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 1.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 1.1 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.1 | 0.2 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.1 | 0.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.1 | 1.5 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.6 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.1 | 0.3 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 0.4 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.1 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.1 | 0.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.4 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.1 | 0.1 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.7 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.1 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.1 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.3 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:2000672 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.3 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 1.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.2 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.7 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.8 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 1.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 1.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.9 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.2 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.1 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 1.1 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 3.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 1.1 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 1.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 1.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.8 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 4.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.5 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.5 | GO:0006582 | melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
0.1 | 2.0 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.1 | 0.5 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.1 | 0.7 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.2 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.1 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.3 | GO:0007625 | grooming behavior(GO:0007625) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 0.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.1 | 1.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.3 | GO:0051231 | spindle elongation(GO:0051231) |
0.1 | 0.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.6 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.7 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.9 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 0.3 | GO:0034776 | response to histamine(GO:0034776) |
0.1 | 1.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 0.4 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.1 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.2 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 2.3 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.8 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.7 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.1 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.3 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.1 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.1 | 0.1 | GO:0021548 | pons development(GO:0021548) |
0.1 | 1.2 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.1 | 1.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.4 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.2 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.1 | 0.7 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.1 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.4 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.1 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.1 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
0.1 | 0.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.2 | GO:0051904 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
0.1 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.1 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.5 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.0 | 0.1 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 1.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.0 | GO:0061156 | pulmonary artery morphogenesis(GO:0061156) |
0.0 | 0.7 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.2 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.0 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.2 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 1.3 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
0.0 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.3 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.1 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.0 | 0.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.0 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 1.8 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.0 | 0.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.0 | 1.2 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.0 | 0.0 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.7 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.4 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.8 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.0 | 0.0 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.0 | 0.0 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.0 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.0 | 0.0 | GO:0051593 | response to folic acid(GO:0051593) |
0.0 | 0.1 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.0 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.0 | 0.3 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.0 | 0.1 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.0 | 0.0 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.0 | 0.7 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.0 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.2 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.1 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 0.0 | GO:0006868 | glutamine transport(GO:0006868) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.0 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.0 | 0.1 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 1.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.0 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.0 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.0 | 0.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.0 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
0.0 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.0 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.2 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.0 | 0.1 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.0 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.0 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.0 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.0 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.0 | 0.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.0 | 0.0 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.2 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.0 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.0 | GO:0051712 | regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
0.0 | 0.0 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.0 | 0.1 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.1 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.0 | 0.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.0 | GO:0070472 | regulation of uterine smooth muscle contraction(GO:0070472) |
0.0 | 0.7 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.1 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.0 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.0 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.3 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.0 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.0 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.1 | GO:0090220 | telomere localization(GO:0034397) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.0 | 0.2 | GO:0043537 | negative regulation of blood vessel endothelial cell migration(GO:0043537) |
0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.5 | GO:0001942 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) |
0.0 | 0.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 0.1 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.0 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.0 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.0 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.0 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0019087 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) transformation of host cell by virus(GO:0019087) |
0.0 | 0.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.0 | 0.0 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.0 | 0.0 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.0 | 0.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:0006057 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.0 | 0.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.0 | 0.0 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.0 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.0 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.2 | GO:0060563 | neuroepithelial cell differentiation(GO:0060563) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.0 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
0.0 | 0.0 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.0 | 0.0 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.0 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.0 | 0.0 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.9 | 9.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 2.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.7 | 2.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 1.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 1.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 15.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 4.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 2.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.5 | 1.9 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 1.8 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.4 | 2.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 3.8 | GO:0005883 | neurofilament(GO:0005883) |
0.4 | 5.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 4.0 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 2.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 1.1 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 16.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 5.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 8.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 0.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 3.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 0.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 44.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.3 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 0.3 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.7 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 2.7 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 1.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 2.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 2.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 6.2 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.1 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 3.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 0.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.2 | 2.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.7 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.2 | 0.2 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.2 | 1.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 1.8 | GO:0097449 | astrocyte projection(GO:0097449) |
0.2 | 10.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.2 | 2.5 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 2.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 1.0 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.2 | 13.8 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 1.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 3.1 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 1.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.8 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 0.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 2.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.9 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 1.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 2.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.5 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.5 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 3.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.6 | GO:0045252 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.4 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.7 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 8.1 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.9 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.5 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.2 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 1.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 3.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 11.0 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 2.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 3.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.3 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.1 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 2.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.6 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 1.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 1.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.7 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.3 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.6 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.6 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 3.9 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.3 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 2.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.0 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 9.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 2.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 1.4 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 1.4 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.5 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.3 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 3.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 0.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.0 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.4 | GO:0098803 | respiratory chain complex(GO:0098803) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.0 | 5.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.7 | 12.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.7 | 8.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 5.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.2 | 3.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.2 | 2.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.9 | 6.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 3.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 5.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.9 | 5.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.9 | 5.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 2.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 3.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.7 | 2.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 1.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 1.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 5.5 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 5.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.6 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 1.7 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.5 | 2.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 0.5 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 1.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 1.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 1.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.5 | 1.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 7.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 2.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 10.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 1.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 1.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.4 | 1.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 0.7 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.4 | 1.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.3 | 2.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 4.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.3 | 2.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 2.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.3 | 2.3 | GO:0043495 | protein anchor(GO:0043495) |
0.3 | 1.7 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 1.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 0.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.3 | 1.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 2.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 7.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 5.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 3.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.9 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 5.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 5.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.3 | 2.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.3 | 3.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 1.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 2.2 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 3.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 0.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 3.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 0.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 0.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 5.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 1.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 0.7 | GO:0008495 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 0.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.8 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 0.6 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 5.7 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.2 | 2.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 3.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 3.5 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 2.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.2 | 0.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 1.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 3.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.2 | 0.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 0.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.2 | 2.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.2 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 0.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 1.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 1.0 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 1.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 2.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 4.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 0.7 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 2.5 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.2 | 1.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 4.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 2.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 3.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.2 | GO:0015556 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 2.0 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 5.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.1 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.6 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.6 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.1 | GO:0018598 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 1.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.1 | 1.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 2.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.5 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 4.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 3.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.2 | GO:0018559 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.6 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.9 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.2 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 0.1 | GO:0050145 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 0.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 0.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 2.2 | GO:0043726 | JUN kinase phosphatase activity(GO:0008579) phosphohistidine phosphatase activity(GO:0008969) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) NADP phosphatase activity(GO:0019178) 5-amino-6-(5-phosphoribitylamino)uracil phosphatase activity(GO:0043726) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) phosphatidylinositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052867) IDP phosphatase activity(GO:1990003) |
0.1 | 2.0 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 1.8 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 4.1 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 1.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 2.2 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 0.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.1 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.5 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 0.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 1.1 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 1.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.6 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 0.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 2.8 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 1.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 2.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 2.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 0.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 3.0 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 2.4 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 1.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.4 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.3 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 1.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.3 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 1.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 6.4 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 2.3 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.6 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.5 | GO:0000975 | regulatory region DNA binding(GO:0000975) transcription regulatory region DNA binding(GO:0044212) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 1.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.8 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 4.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 4.5 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.1 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.0 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.0 | 0.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.8 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.0 | 0.1 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.3 | GO:0018649 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.0 | 0.0 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 1.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.1 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 1.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.0 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 2.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.6 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.3 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 1.0 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.0 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 5.3 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.0 | 0.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 1.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.0 | 1.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.4 | GO:0052634 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.0 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 1.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.2 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.0 | 0.0 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 19.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.5 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.0 | 1.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.0 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.0 | 0.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 10.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 7.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 6.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 8.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 3.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 17.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 3.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 4.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 4.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 4.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 3.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 0.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 5.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 3.1 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 2.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 1.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.4 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 11.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 1.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 3.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.0 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 9.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 13.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 7.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.4 | 0.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 7.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 0.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 2.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 4.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 3.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 4.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.3 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 7.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.3 | 6.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.2 | 7.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.2 | 2.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 2.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 7.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 4.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 1.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 3.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.5 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 3.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 4.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 2.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 2.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 1.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.3 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 6.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 5.8 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 1.4 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 3.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.1 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 0.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 2.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.1 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.0 | 2.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 2.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 0.2 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.6 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 2.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.0 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 2.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 3.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.0 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.7 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.0 | 0.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |